Comment on selenium supplementation in Brazilian cardiac patients
International Journal of Development Research
Comment on selenium supplementation in Brazilian cardiac patients
Received 18th April, 2018; Received in revised form 20th May, 2018; Accepted 06th June, 2018; Published online 30th July, 2018
Copyright © 2018, Marlice Oliveira de Oliveira Ulbrecht et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Selenium is an essential element for human health, possessing antioxidant role and present in several selenoproteins. Objective: This manuscript aims to make a commentary from the survey of the mortality rate of cardiac patients in the last years and to evaluate the decision making of studies on the intake of selenium in Brazilian cardiac patients. Methods: We searched Medline, Pubmed, and SciELO for studies evaluating selenium and cardiovascular outcomes in patients. So we select and extract the data.Results: The results show that the average mortality rates in Brazil have increased in the last years. The studies revealed that there are no significance levels in daily supplements and levels of Tolerable Superior Ingestion for cardiac patients. In fact, recommended daily (RDI) and tolerable upper intake (UL) are standardized for healthy people. Conclusion: Studies should be performed to determine the RDI dose and UL for cardiac patients of various age ranges.
